Geode Capital Management, LLC Ligand Pharmaceuticals Inc Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 464,452 shares of LGND stock, worth $52.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
464,452
Previous 438,441
5.93%
Holding current value
$52.3 Million
Previous $47 Million
3.95%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding LGND
# of Institutions
280Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$323 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$231 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$116 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$102 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$83.8 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.9B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...